Flecainide Acetate
- Product NDC
- 63629-7979
- Requested package NDC
- 63629-7979-2
- 11-digit product format
- 636297979
- Labeler code
- 63629
- Product ID
- 63629-7979_3d65643b-e585-4e81-8792-9089e0fbabd6
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Flecainide Acetate
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Bryant Ranch Prepack
- Application
- ANDA202821
- Marketing category
- ANDA
- Marketing start
- 2015-07-08
- Substance
- FLECAINIDE ACETATE
- Active strength
- 50 mg/1
- Pharmacologic classes
- Antiarrhythmic [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
NDC auxiliary status#
These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.
| Dataset | Scope | Product NDC | Package NDC | Code | Status | Reporting period | Source date |
|---|---|---|---|---|---|---|---|
| excluded package | package | 63629-7979 | 63629-7979-2 | D | Discontinued by firm | 2026-08-11 |
Observed NDC auxiliary status history#
This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
| Captured / source date | Snapshot | Source SHA-256 |
|---|---|---|
| 2025-12-14 17:58 UTC · source 2025-12-05 | d630ba8d3edf… | 732f749b63fb… |
| 2025-08-27 00:01 UTC · source 2025-08-26 | f5e01cc5f278… | a2eaf40c39c3… |
| 2025-04-01 02:39 UTC · source 2025-03-31 | 2ef7874e63bc… | 57b86245f4fa… |
| 2025-03-28 20:22 UTC · source 2025-03-28 | a1b67e2a42f9… | c4cf2c586c0d… |
| 2025-03-22 03:12 UTC · source 2025-03-21 | cfe11265f3b6… | 090c488252e2… |
| 2025-03-10 12:48 UTC · source 2025-03-10 | cdf11ea48f46… | ba0047e9e063… |
| 2025-02-02 03:52 UTC · source 2025-01-31 | 302b2466d912… | e7b80fea0513… |
| 2025-01-20 13:05 UTC · source 2025-01-20 | ed331223b511… | 672a5bd82f5f… |
| 2025-01-11 03:41 UTC · source 2025-01-10 | 0efc9e666f02… | f202fb6c5f17… |
| 2024-11-09 02:27 UTC · source 2024-11-08 | ad56d346431e… | cc804d4bbf1e… |
| 2024-10-04 04:10 UTC · source 2024-10-03 | 367a005e9d99… | 383a685ebd0f… |
| 2024-07-10 04:00 UTC · source 2024-07-09 | 557ba5c1ecfa… | 9c80585c8c6e… |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A202821-001 | FLECAINIDE ACETATE | FLECAINIDE ACETATE | 50MG | TABLET / ORAL | AB | 2017-11-03 | |
| A202821-002 | FLECAINIDE ACETATE | FLECAINIDE ACETATE | 100MG | TABLET / ORAL | AB | 2017-11-03 | |
| A202821-003 | FLECAINIDE ACETATE | FLECAINIDE ACETATE | 150MG | TABLET / ORAL | AB | 2017-11-03 |
Therapeutic equivalence codes#
| Application-product | TE code |
|---|---|
| A202821-001 | AB |
| A202821-002 | AB |
| A202821-003 | AB |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | A202821-001 | FLECAINIDE ACETATE | 50MG | TABLET / ORAL | AB | 2017-11-03 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A202821-002 | FLECAINIDE ACETATE | 100MG | TABLET / ORAL | AB | 2017-11-03 | 011fe1cb6892… | |
| 2026-02-19 14:30 UTC | 2026-02 | A202821-003 | FLECAINIDE ACETATE | 150MG | TABLET / ORAL | AB | 2017-11-03 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A202821-001 | FLECAINIDE ACETATE | 50MG | TABLET / ORAL | AB | 2017-11-03 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A202821-002 | FLECAINIDE ACETATE | 100MG | TABLET / ORAL | AB | 2017-11-03 | 31067a03dcf5… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A202821-003 | FLECAINIDE ACETATE | 150MG | TABLET / ORAL | AB | 2017-11-03 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | A202821-001 | FLECAINIDE ACETATE | 50MG | TABLET / ORAL | AB | 2017-11-03 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | A202821-002 | FLECAINIDE ACETATE | 100MG | TABLET / ORAL | AB | 2017-11-03 | 6a471c1ec25d… | |
| 2025-08-23 18:47 UTC | 2025-08 | A202821-003 | FLECAINIDE ACETATE | 150MG | TABLET / ORAL | AB | 2017-11-03 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A202821-001 | FLECAINIDE ACETATE | 50MG | TABLET / ORAL | AB | 2017-11-03 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A202821-002 | FLECAINIDE ACETATE | 100MG | TABLET / ORAL | AB | 2017-11-03 | fd3edfee7708… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A202821-003 | FLECAINIDE ACETATE | 150MG | TABLET / ORAL | AB | 2017-11-03 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A202821-001 | FLECAINIDE ACETATE | 50MG | TABLET / ORAL | AB | 2017-11-03 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A202821-002 | FLECAINIDE ACETATE | 100MG | TABLET / ORAL | AB | 2017-11-03 | b8a1b40f171c… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A202821-003 | FLECAINIDE ACETATE | 150MG | TABLET / ORAL | AB | 2017-11-03 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A202821-001 | FLECAINIDE ACETATE | 50MG | TABLET / ORAL | AB | 2017-11-03 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A202821-002 | FLECAINIDE ACETATE | 100MG | TABLET / ORAL | AB | 2017-11-03 | 03ed91905a0d… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A202821-003 | FLECAINIDE ACETATE | 150MG | TABLET / ORAL | AB | 2017-11-03 | 03ed91905a0d… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A202821-001 | FLECAINIDE ACETATE | 50MG | TABLET / ORAL | AB | 2017-11-03 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A202821-002 | FLECAINIDE ACETATE | 100MG | TABLET / ORAL | AB | 2017-11-03 | 2680178bc6a6… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A202821-003 | FLECAINIDE ACETATE | 150MG | TABLET / ORAL | AB | 2017-11-03 | 2680178bc6a6… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A202821-001 | FLECAINIDE ACETATE | 50MG | TABLET / ORAL | AB | 2017-11-03 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A202821-002 | FLECAINIDE ACETATE | 100MG | TABLET / ORAL | AB | 2017-11-03 | 5bbf6a4d5a75… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A202821-003 | FLECAINIDE ACETATE | 150MG | TABLET / ORAL | AB | 2017-11-03 | 5bbf6a4d5a75… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A202821-001 | FLECAINIDE ACETATE | 50MG | TABLET / ORAL | AB | 2017-11-03 | d8e5a09893c0… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A202821-002 | FLECAINIDE ACETATE | 100MG | TABLET / ORAL | AB | 2017-11-03 | d8e5a09893c0… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A202821-003 | FLECAINIDE ACETATE | 150MG | TABLET / ORAL | AB | 2017-11-03 | d8e5a09893c0… | |
| 2024-10-29 15:01 UTC | 2024-10 | A202821-001 | FLECAINIDE ACETATE | 50MG | TABLET / ORAL | AB | 2017-11-03 | d06236e962d9… | |
| 2024-10-29 15:01 UTC | 2024-10 | A202821-002 | FLECAINIDE ACETATE | 100MG | TABLET / ORAL | AB | 2017-11-03 | d06236e962d9… | |
| 2024-10-29 15:01 UTC | 2024-10 | A202821-003 | FLECAINIDE ACETATE | 150MG | TABLET / ORAL | AB | 2017-11-03 | d06236e962d9… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A202821-001 | FLECAINIDE ACETATE | 50MG | TABLET / ORAL | AB | 2017-11-03 | 79d66fd596c7… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A202821-002 | FLECAINIDE ACETATE | 100MG | TABLET / ORAL | AB | 2017-11-03 | 79d66fd596c7… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A202821-003 | FLECAINIDE ACETATE | 150MG | TABLET / ORAL | AB | 2017-11-03 | 79d66fd596c7… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A202821-001 | FLECAINIDE ACETATE | 50MG | TABLET / ORAL | AB | 2017-11-03 | 301d65b070ca… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A202821-002 | FLECAINIDE ACETATE | 100MG | TABLET / ORAL | AB | 2017-11-03 | 301d65b070ca… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A202821-003 | FLECAINIDE ACETATE | 150MG | TABLET / ORAL | AB | 2017-11-03 | 301d65b070ca… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A202821-001 | FLECAINIDE ACETATE | 50MG | TABLET / ORAL | AB | 2017-11-03 | 1e350fbaab3a… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A202821-002 | FLECAINIDE ACETATE | 100MG | TABLET / ORAL | AB | 2017-11-03 | 1e350fbaab3a… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A202821-003 | FLECAINIDE ACETATE | 150MG | TABLET / ORAL | AB | 2017-11-03 | 1e350fbaab3a… | |
| 2024-05-31 18:47 UTC | 2024-05 | A202821-001 | FLECAINIDE ACETATE | 50MG | TABLET / ORAL | AB | 2017-11-03 | 8072bd15b7f6… |
Observed Orange Book normalized TE history#
| Captured | Edition | Application-product | TE code | Order | Source SHA-256 |
|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | A202821-001 | AB | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A202821-002 | AB | 1 | 011fe1cb6892… |
| 2026-02-19 14:30 UTC | 2026-02 | A202821-003 | AB | 1 | 011fe1cb6892… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A202821-001 | AB | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A202821-002 | AB | 1 | 31067a03dcf5… |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A202821-003 | AB | 1 | 31067a03dcf5… |
| 2025-08-23 18:47 UTC | 2025-08 | A202821-001 | AB | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | A202821-002 | AB | 1 | 6a471c1ec25d… |
| 2025-08-23 18:47 UTC | 2025-08 | A202821-003 | AB | 1 | 6a471c1ec25d… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A202821-001 | AB | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A202821-002 | AB | 1 | fd3edfee7708… |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A202821-003 | AB | 1 | fd3edfee7708… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A202821-001 | AB | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A202821-002 | AB | 1 | b8a1b40f171c… |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A202821-003 | AB | 1 | b8a1b40f171c… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A202821-001 | AB | 1 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A202821-002 | AB | 1 | 03ed91905a0d… |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A202821-003 | AB | 1 | 03ed91905a0d… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A202821-001 | AB | 1 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A202821-002 | AB | 1 | 2680178bc6a6… |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A202821-003 | AB | 1 | 2680178bc6a6… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A202821-001 | AB | 1 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A202821-002 | AB | 1 | 5bbf6a4d5a75… |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A202821-003 | AB | 1 | 5bbf6a4d5a75… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A202821-001 | AB | 1 | d8e5a09893c0… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A202821-002 | AB | 1 | d8e5a09893c0… |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A202821-003 | AB | 1 | d8e5a09893c0… |
| 2024-10-29 15:01 UTC | 2024-10 | A202821-001 | AB | 1 | d06236e962d9… |
| 2024-10-29 15:01 UTC | 2024-10 | A202821-002 | AB | 1 | d06236e962d9… |
| 2024-10-29 15:01 UTC | 2024-10 | A202821-003 | AB | 1 | d06236e962d9… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A202821-001 | AB | 1 | 79d66fd596c7… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A202821-002 | AB | 1 | 79d66fd596c7… |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A202821-003 | AB | 1 | 79d66fd596c7… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A202821-001 | AB | 1 | 301d65b070ca… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A202821-002 | AB | 1 | 301d65b070ca… |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A202821-003 | AB | 1 | 301d65b070ca… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A202821-001 | AB | 1 | 1e350fbaab3a… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A202821-002 | AB | 1 | 1e350fbaab3a… |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A202821-003 | AB | 1 | 1e350fbaab3a… |
| 2024-05-31 18:47 UTC | 2024-05 | A202821-001 | AB | 1 | 8072bd15b7f6… |
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Flecainide Acetate
- Listing expiration
- 2026-12-31
Active Ingredients#
| Ingredient | Strength |
|---|---|
| FLECAINIDE ACETATE | 50 mg/1 |
Harmonized UNII identifiers#
| Identifier | FDA.report destination |
|---|---|
| M8U465Q1WQ | Internal UNII lookup |
Harmonized RxCUI identifiers#
| Identifier | FDA.report destination |
|---|---|
| 886662 | Internal RxNorm lookup |
Harmonized SPL set identifiers#
| Identifier | FDA.report destination |
|---|---|
| 5d6a4772-663e-468d-a8e1-4085e1b32bf7 | Available on FDA.report |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| 47936aaf-dd8f-a65f-335e-74a6c45bbd64 | Product name | 5 | 20231128 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 63629-7979-1 | Flecainide Acetate | 30 in 1 BOTTLE | TABLET | 30 | 104 | |
| 63629-7979-2 | Flecainide Acetate | 60 in 1 BOTTLE | TABLET | 60 | 104 | |
| 63629-7979-3 | Flecainide Acetate | 90 in 1 BOTTLE | TABLET | 90 | 104 | |
| 63629-7979-4 | Flecainide Acetate | 10 in 1 BOTTLE | TABLET | 10 | 104 | |
| 63629-7979-5 | Flecainide Acetate | 180 in 1 BOTTLE | TABLET | 180 | 104 |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 63629-7979-2 | EA - Each | 63629-7979 | 48d57ef2-1448-4d45-aa20-e11f315b44e6 | 1 | 2025-08-11 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 63629-7979 | FLECAINIDE ACETATE TABLET [BRYANT RANCH PREPACK] | 104 | Current NDC, Legacy NDC, 5 package rows | 20240502_5d6a4772-663e-468d-a8e1-4085e1b32bf7.zip |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Flecainide Acetate | FLECAINIDE ACETATE | A-S Medication Solutions | 475a52a9-f18c-4a69-91f0-8f5e601f4336 | 2024-11-13 | Boxed warning, Adverse reactions | 202821 ANDA202821 |
| Flecainide Acetate | FLECAINIDE ACETATE | Bryant Ranch Prepack | 6b73e32f-851b-4503-8296-e5db3a584b75 | 2024-05-24 | Boxed warning, Adverse reactions | 202821 ANDA202821 |
| Flecainide Acetate | FLECAINIDE ACETATE | Bryant Ranch Prepack | 2013e6ef-9141-42c3-8ea8-285840ecdd15 | 2024-04-03 | Boxed warning, Adverse reactions | 202821 ANDA202821 |
| Flecainide Acetate | FLECAINIDE ACETATE | Bryant Ranch Prepack | 5d6a4772-663e-468d-a8e1-4085e1b32bf7 | 2024-04-03 | Boxed warning, Adverse reactions | 202821 ANDA202821 63629-7979-2 63629-7979 63629797902 |
| Flecainide Acetate | FLECAINIDE ACETATE | Aurobindo Pharma Limited | 14e89448-3a18-42e3-8537-2589be1ef94e | 2024-01-09 | Boxed warning, Adverse reactions | 202821 ANDA202821 |
| Flecainide Acetate | FLECAINIDE ACETATE | Rising Pharma Holdings, Inc. | e56335c1-5508-4136-bd2e-18385623e497 | 2024-01-09 | Boxed warning, Adverse reactions | 202821 ANDA202821 |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 886662 | flecainide acetate 50 MG Oral Tablet | PSN | 5d6a4772-663e-468d-a8e1-4085e1b32bf7 | 104 |
| 886662 | flecainide acetate 50 MG Oral Tablet | SCD | 5d6a4772-663e-468d-a8e1-4085e1b32bf7 | 104 |
Packages#
| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|---|---|---|---|---|---|---|---|
| 63629-7979-2 | 63629797902 | 60 TABLET in 1 BOTTLE (63629-7979-2) | 60 tablet | 2019-03-28 | 0000-00-00 | No | No | Current |